ReproCELL Balance Sheet Health
Financial Health criteria checks 6/6
ReproCELL has a total shareholder equity of ¥8.7B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥9.4B and ¥681.0M respectively.
Key information
0%
Debt to equity ratio
JP¥0
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥5.17b |
| Equity | JP¥8.74b |
| Total liabilities | JP¥681.00m |
| Total assets | JP¥9.42b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 4978's short term assets (¥6.0B) exceed its short term liabilities (¥642.0M).
Long Term Liabilities: 4978's short term assets (¥6.0B) exceed its long term liabilities (¥39.0M).
Debt to Equity History and Analysis
Debt Level: 4978 is debt free.
Reducing Debt: 4978 has no debt compared to 5 years ago when its debt to equity ratio was 1.2%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4978 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4978 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 19.9% each year